Related Articles
Clinical evidence of the relationship between aspirin and breast cancer risk (Review)
Multidrug resistance and rhabdomyosarcoma (Review)
HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)
Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)
Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review)